TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- ...

Edwards Lifesciences has secured European approval for its transcatheter tricuspid valve replacement system, which the company described as the first minimally invasive therapy of its kind to receive ...

Edwards Lifesciences has claimed the FDA’s first approval of a transcatheter replacement implant for a leaky tricuspid heart valve, three months after garnering a green light in Europe. The Evoque, ...

CHICAGO -- Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heart failure (HF) hospitalization ...

PARIS, France—Percutaneous edge-to-edge repair with a clip device appears to offer some hope for patients with tricuspid regurgitation, according to new results from the TRILUMINATE study. At 30 days, ...

People with tricuspid regurgitation (TR) are heavily reliant on care from their adult children and generally would like more and earlier education about their condition—these are the messages that ...

The investigational transfemoral EVOQUE tricuspid valve replacement system (Edwards Lifesciences) significantly reduced severity of tricuspid regurgitation and improved quality of life at 30 days in ...

Tricuspid valve repair at the time of mitral-valve surgery reduces tricuspid regurgitation progression but at the cost of more than a 5-fold increase in permanent pacemakers, a new Cardiothoracic ...

LAS VEGAS, Nev. (FOX5) - Grayson Gallardo is an 11-year-old boy who has a bright smile and big dreams. Gallardo was born with a rare congenital heart defect called Tricuspid atresia. His condition ...